Zelira share price rockets as study shows cannabinoid drug outperforms multibillion dollar Pfizer product by Steve Jones June 1, 2023June 1, 2023 ASX-listed Zelira Therapeutics saw its share price soar 230% yesterday after revealing its cannabinoid medication for […]
Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma by Martin Lane and Steve Jones May 23, 2023May 23, 2023
Company news: Wellnex Life; Creso Pharma; MGC Pharma; Zelira Therapeutics by Martin Lane March 16, 2023March 16, 2023
Company news: Neurotech; Emyria; Cann Group; Incannex; Creso Pharma; Greenfern; Zelira; Organic Genetics by Martin Lane November 24, 2022November 24, 2022
Company news: Zelira Therapeutics; Hygrovest; Epsilon Healthcare by Martin Lane September 22, 2022September 22, 2022
Financial results: Avecho; AusCann; Zelira; Elixinol; Cann Group; Incannex; Creso Pharma; Medlab; Rua Bioscience by Steve Jones and Martin Lane September 1, 2022September 1, 2022
Zelira’s ‘multiple shots on goal’ will drive profitability, says global CEO by Steve Jones June 30, 2022July 7, 2022
Zelira’s Health House acquisition called off by Martin Lane and Steve Jones June 22, 2022June 23, 2022
Company news: Wellnex Life; Incannex; Tetra Bio-Pharma; Zelira by Martin Lane June 8, 2022June 9, 2022
Company news: Helius; Greenfern Industries; Zelira; Creso Pharma; Emyria; Roto-Gro International by Martin Lane June 2, 2022June 2, 2022